Registered number
10781326
Shish Patel Pharma Consulting Ltd
Unaudited Filleted Accounts
31 May 2024
Shish Patel Pharma Consulting Ltd
Registered number: 10781326
Balance Sheet
as at 31 May 2024
Notes 2024 2023
£ £
Current assets
Debtors 4 34 163
Cash at bank and in hand 32,740 33,291
32,774 33,454
Creditors: amounts falling due within one year 5 (14,608) (9,671)
Net current assets 18,166 23,783
Net assets 18,166 23,783
Capital and reserves
Called up share capital 10 10
Profit and loss account 18,156 23,773
Shareholders' funds 18,166 23,783
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Shishir Patel
Director
Approved by the board on 10 October 2024
Shish Patel Pharma Consulting Ltd
Notes to the Accounts
for the year ended 31 May 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Equipment etc
£
Cost
At 1 June 2023 3,583
At 31 May 2024 3,583
Depreciation
At 1 June 2023 3,583
At 31 May 2024 3,583
Net book value
At 31 May 2024 -
4 Debtors 2024 2023
£ £
Other taxes and social security costs 34 163
5 Creditors: amounts falling due within one year 2024 2023
£ £
Other creditors 14,608 9,671
6 Controlling party
As at the balance sheet date, Shishir Patel is the controlling party by virtue of his shareholding.
7 Other information
Shish Patel Pharma Consulting Ltd is a private company limited by shares and incorporated in England. Its registered office is:
53 Marcliff Grove
Stockport
Cheshire
SK4 2AB
Shish Patel Pharma Consulting Ltd 10781326 false 2023-06-01 2024-05-31 2024-05-31 VT Final Accounts July 2024 Mr Shishir Patel No description of principal activity 10781326 2022-06-01 2023-05-31 10781326 core:WithinOneYear 2023-05-31 10781326 core:ShareCapital 2023-05-31 10781326 core:RetainedEarningsAccumulatedLosses 2023-05-31 10781326 2023-06-01 2024-05-31 10781326 bus:EntityNoLongerTradingButTradedInPast 2023-06-01 2024-05-31 10781326 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 10781326 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 10781326 bus:Director40 2023-06-01 2024-05-31 10781326 1 2023-06-01 2024-05-31 10781326 2 2023-06-01 2024-05-31 10781326 countries:England 2023-06-01 2024-05-31 10781326 bus:FRS102 2023-06-01 2024-05-31 10781326 bus:FilletedAccounts 2023-06-01 2024-05-31 10781326 2024-05-31 10781326 core:WithinOneYear 2024-05-31 10781326 core:ShareCapital 2024-05-31 10781326 core:RetainedEarningsAccumulatedLosses 2024-05-31 10781326 core:PlantMachinery 2024-05-31 10781326 2023-05-31 10781326 core:PlantMachinery 2023-05-31 iso4217:GBP xbrli:pure